Proparacaine HCl Ophthalmic Solution Rx
Generic Name and Formulations:
Proparacaine HCl 0.5%; contains benzalkonium chloride.
Various generic manufacturers
Indications for Proparacaine HCl Ophthalmic Solution:
For procedures in which a topical ophthalmic anesthetic is indicated: corneal anesthesia of short duration (eg, tonometry, gonioscopy, removal of corneal foreign bodies), and for short corneal and conjunctival procedures.
Adults and Children:
Removal of foreign bodies and sutures, and for tonometry: 1–2 drops in each eye before operating. Short corneal and conjunctival procedures: 1 drop in each eye every 5–10 minutes for 5–7 doses.
Not for injection into eye. Permanent corneal opacification with accompanying visual loss with prolonged use. Pregnancy (Cat.C). Nursing mothers.
Rapidly-acting topical anesthetic.
Local effects (eg, stinging, burning, conjunctival redness); rare: severe, immediate-type hyperallergic corneal reaction.
Formerly known under the brand name Ophthetic.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Adjunctive Therapies for Bipolar Disorder Show Promise, Need More Evidence
- Improving Performance of Everyday Activities Is Critical in Schizophrenia
- Analysis Finds Lithium Maintenance Most Effective as Monotherapy in Bipolar Disorder
- Web-Based Intervention Targets Parental Behaviors That May Affect Adolescent Anxiety, Depression
- Abnormalities of Cortical Thickness in Bipolar Disorder With Auditory Hallucinations
- The Way to the Head May Be Through the Gut: Probiotics for Depression
- Suicide-Screening Toolkit Can Help Identify Youths at High Risk for Suicide
- Agoraphobia: An Evolving Understanding of Definitions and Treatment
- Parental Pressure to Diet Linked With Long-term Harm in Adolescents
- Does Access to Medical Cannabis Reduce Risk for Opioid Abuse?
- Antidepressants Increase Seizure Risk in Youth and Severely Depressed
- Examining Associations Between Diabetes and Effects on Cognition
- Untreated Depression Common in Women of Childbearing Age
- Incidence of Psychiatric Disorders in Rheumatoid Arthritis
- Effect of Antidepressant Class, Dose on Pediatric Anxiety Disorders